Human papillomavirus infection by anatomical site among Greek men and women: a systematic review
- PMID: 26628088
- PMCID: PMC4884171
- DOI: 10.1097/CEJ.0000000000000207
Human papillomavirus infection by anatomical site among Greek men and women: a systematic review
Abstract
We systematically reviewed the literature on anal, penile, cervical, and oropharyngeal human papillomavirus (HPV) infection in Greece to provide a comprehensive overview of HPV prevalence and to explore the reporting of HPV in Greek men and women. A total of five databases, including PubMed and Scopus, were searched up until 1 January 2015 for studies looking at HPV prevalence, incidence, or risk factors by anatomical site. We identified 50 eligible studies for inclusion. The majority of them were cervical studies (n=26) followed by head and neck studies (n=13) with only two studies exclusively focusing on anal sites and two on penile sites. The remaining studies examined prevalence from multiple sites. Most studies looked at small, high-risk populations, and HPV prevalence ranged from 2.5-43.4% for cervical studies; 0-91% for head and neck studies; 54.6-78.4% for anal studies; and 20.3-66.7% for penile studies. Age, smoking, and number of sexual partners were the commonly assessed risk factors. There were significant sex and anatomic site disparities in the reporting of HPV prevalence. Given the relationship between HPV infection and the increasing incidence of anal cancer in men, more research is needed to reveal the prevalence of HPV at these sites in Greek men, especially given the reports of the declining health of the Greek population.
Conflict of interest statement
The authors of this review have no conflicts of interest to report.
Figures
Similar articles
-
Disparities in Human Papillomavirus-Associated Cancer Incidence by Appalachian Residence.JAMA Netw Open. 2025 Jun 2;8(6):e2518242. doi: 10.1001/jamanetworkopen.2025.18242. JAMA Netw Open. 2025. PMID: 40587129 Free PMC article.
-
Racial and ethnic differences in HPV-related cancer incidence in the United States, 2001-2020.J Natl Cancer Inst. 2025 Aug 1;117(8):1655-1663. doi: 10.1093/jnci/djaf107. J Natl Cancer Inst. 2025. PMID: 40289254
-
HPV cancer burden by anatomical site, country, and region in 2022.Sci Rep. 2025 Jul 1;15(1):21048. doi: 10.1038/s41598-025-06700-8. Sci Rep. 2025. PMID: 40593150 Free PMC article.
-
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.Lancet Glob Health. 2023 Sep;11(9):e1345-e1362. doi: 10.1016/S2214-109X(23)00305-4. Lancet Glob Health. 2023. PMID: 37591583 Free PMC article.
-
Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.Am J Obstet Gynecol. 2015 Sep;213(3):278-309. doi: 10.1016/j.ajog.2015.03.034. Epub 2015 Mar 19. Am J Obstet Gynecol. 2015. PMID: 25797230 Free PMC article.
Cited by
-
Knowledge, Attitudes and Perceptions about Cervical Cancer Risk, Prevention and Human Papilloma Virus (HPV) in Vulnerable Women in Greece.Int J Environ Res Public Health. 2020 Sep 21;17(18):6892. doi: 10.3390/ijerph17186892. Int J Environ Res Public Health. 2020. PMID: 32967173 Free PMC article.
-
Type-specific concurrent anogenital HPV detection among young women and MSM attending Dutch sexual health clinics.Sex Transm Infect. 2022 Jul 16;99(4):239-47. doi: 10.1136/sextrans-2022-055484. Online ahead of print. Sex Transm Infect. 2022. PMID: 35842228 Free PMC article.
-
HPV vaccine acceptability in high-risk Greek men.Hum Vaccin Immunother. 2018 Jan 2;14(1):134-139. doi: 10.1080/21645515.2017.1379640. Epub 2017 Oct 24. Hum Vaccin Immunother. 2018. PMID: 28937851 Free PMC article.
-
Risk factors, prevalence, and site concordance of human papillomavirus in high-risk Greek men.Eur J Cancer Prev. 2018 Sep;27(5):514-520. doi: 10.1097/CEJ.0000000000000366. Eur J Cancer Prev. 2018. PMID: 28394804 Free PMC article.
References
-
- Aggelopoulou EP, Skarlos D, Papadimitriou C, Kittas C, Troungos C. Human papilloma virus DNA detection in oral lesions in the Greek population. Anticancer Res. 1999;19(2B):1391–1395. - PubMed
-
- Agorastos T, Bontis J, Lambropoulos AF, Constantinidis TC, Nasioutziki M, Tagou C, et al. Epidemiology of human papillomavirus infection in Greek asymptomatic women. Eur J Cancer Prev. 1995;4(2):159–167. - PubMed
-
- Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis TC, et al. Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study. Eur J Cancer Prev. 2014;23(5):425–431. - PubMed
-
- Agorastos T, Dinas K, Lloveras B, Bosch FX, Kornegay JR, Bontis JN, et al. Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece. Eur J Cancer Prev. 2004;13(2):145–147. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical